Blueprint increases deal flow and exposure to global partnering opportunities via our network of academic institutions, corporate entities, venture capital firms and investment banks. By providing a client with a complete look into the global environment, Blueprint enables management teams to evaluate their competitive arena of emerging private and public companies. This deep understanding of corporate/clinical position assists with the development of in/out licensing strategy, clinical trial planning, partnership candidates and pipeline management.